Exercise modulates platelet-nasopharyngeal carcinoma cell aggregation and subsequent tissue factor and matrix metalloproteinase activities

Journal of Applied Physiology

Volumn 103, Issue 3, 2007, Pages 763-770

  Wang, Jong Shyan ^a   Chang, Chuen Ying ^a   Chow, Shu Er ^a   Chen, Yu Wen ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cell interaction; Exercise intensity; Thrombosis; Tumor

Indexed keywords

FIBRINOGEN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROTHROMBIN; THROMBOPLASTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR RISK; CELL AGGREGATION; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; METASTASIS; NASOPHARYNX CARCINOMA; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK REDUCTION; THROMBOCYTE; THROMBOSIS;

ADULT; BLOOD PLATELETS; CARCINOMA; CELL AGGREGATION; EXERCISE; HUMANS; LIPOPROTEINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; THROMBOPLASTIN; THROMBOSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 34548454017     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00165.2007     Document Type: Article

References (43)

1. Alonso-Escolano D, Strongin AY, Chung AW, Deryugina EI, Radomski MW. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol 141: 241-252, 2004.
2. Alonso-Escolano D, Medina C, Cieslik K, Radomski A, Jurasz P, Santos-Martinez MJ, Jiffar T, Ruvolo P, Radomski MW. Protein kinase C delta mediates platelet-induced breast cancer cell invasion. J Pharmacol Exp Ther 318: 373-380, 2006.
3. Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost 2: 1266 -1271, 2004.
4. Amirkhosravi A, Meyer T, Chang JY, Amaya M, Siddiqui F, Desai H, Francis JL. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost 87: 930-936, 2002.
5. Amirkhosravi A, Mousa SA, Amaya M, Blaydes S, Desai H, Meyer T, Francis JL. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 90: 549-554, 2003.
6. Amirkhosravi A, Mousa SA, Amaya M, Francis JL. Antimetastatic effect of tinzaparin, a low-molecular-weight heparin. J Thromb Haemost 1: 1972-1976, 2003.
7. Belaaouaj AA, Li A, Wun TC, Welgus HG, Shapiro SD. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem 275: 27123-27128, 2000.
8. Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104: 397-401, 2004.
9. Chan ATC, Teo PML, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 13: 1007-1015, 2002.
10. Dardik R, Kaufmann Y, Savion N, Rosenberg N, Shenkman B, Varon D. Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha(v) integrins. Int J Cancer 70: 201-207, 1997.
11. Davis JM, Kohut ML, Jackson DA, Colbert LH, Mayer EP, Ghaffar A. Exercise effects on lung tumor metastases and in vitro alveolar macrophage antitumor cytotoxicity. Am J Physiol Regul Integr Comp Physiol 274: R1454-R1459, 1998.
12. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
13. Felding-Habermann B, Ruggeri ZM, Cheresh DA. Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 267: 5070-5077, 1992.
14. Francis JL, Amirkhosravi A. Effect of antihemostatic agents on experimental tumor dissemination. Semin Thromb Hemost 28: 29-38, 2002.
15. Glanemann M, Vollmar B, Nussler AK, Schaefer T, Neuhaus P, Menger MD. Ischemic preconditioning protects from hepatic ischemia/reperfusion- injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol 38: 59-66, 2005.
16. Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115: 849-860, 2005.
17. Huang GW, Nong HT, Nakamura M, Kosugi T. Enhancement of platelet aggregation in patients with nasopharyngeal carcinoma. Auris Nasus Larynx 21: 173-177, 1994.
18. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113: 752-760, 2005.
19. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245-2252, 2002.
20. Jurasz P, Alonso-Escolano D, Radomski MW. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143: 819-826, 2004.
21. Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, Rustin G, Thomas M, Quigley M, Williamson RC. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 22: 1944-1948, 2004.
22. Kosugi T, Takagi I, Ariga Y, Okada S, Morimitsu T, Mihara H. Fibrinolysis-coagulation system in patients with cancer of the head and neck. Preliminary report. Arch Otorhinolaryngol 236: 211-215, 1982.
23. Langer F, Amirkhosravi A, Ingersoll SB, Walker JM, Spath B, Eifrig B, Bokemeyer C, Francis JL. Experimental metastasis and primary tumor growth in mice with hemophilia A. J Thromb Haemost 4: 1056-1062, 2006.
24. Lee KW, Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 163: 2368-2392, 2003.
25. MacNeil B, Hoffman-Goetz L. Exercise training and tumour metastasis in mice: influence of time of exercise onset. Anticancer Res 13: 2085-2088, 1993.
26. Oliveria SA, Christos PJ. The epidemiology of physical activity and cancer. Ann NY Acad Sci 833: 79-90, 1997.
27. Ordinas A, Diaz-Ricart M, Almirall L, Bastida E. The role of platelets in cancer metastasis. Blood Coagul Fibrinolysis 1: 707-711, 1990.
28. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, Bugge TH. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96: 3302-3309, 2000.
29. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirouskova M, Degen JL. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105: 178-185, 2005.
30. Paraskevaidis IA, Iliodromitis EK, Mavrogeni S, Karavolias GK, Theodorakis GN, Georgiadis M, Kremastinos DT. Repeated exercise stress testing identifies early and late preconditioning. Int J Cardiol 98: 221-226, 2005.
31. 2-reactive species activate primed platelets in human whole blood. Am J Physiol Heart Circ Physiol 264: H1582-H1587, 1993.
32. Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 32: 54-70, 2006.
33. Suzuki K, Aiura K, Ueda M, Kitajima M. The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents. Pancreas 29: 132-140, 2004.
34. Wang JS, Cheng LJ. Effect of strenuous, acute exercise on alpha 2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol 19: 1559-1565, 1999.
35. Wang JS, Jen CJ, Kung HC, Lin LJ, Hsiue TR, Chen HI. Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation 90: 2877-2885, 1994.
36. Wang JS. Exercise prescription and thrombogenesis. J Biomed Sci 13: 753-761, 2006.
37. Wang JS, Li YS, Chen JC, Chen YW. Effects of exercise training and deconditioning on platelet aggregation induced by alternating shear stress in men. Arterioscler Thromb Vasc Biol 25: 454-460, 2005.
38. Wang JS, Yen HL, Yang CM. Warm-up exercise suppresses plateleteosinophil/neutrophil aggregation and platelet-promoted release of eosinophil/neutrophil oxidant products enhanced by severe exercise in men. Thromb Haemost 95: 490-498, 2006.
39. Wang JS. Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willbrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets. Eur J Appl Physiol 91: 741-747, 2004.
40. Wang JS, Liao CH. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocytes interaction with surface-adherentplatelets under shear flow in men. Thromb Haemost 91: 587-594, 2004.
41. Wang JS, Huang YH. Effects of exercise intensity on lymphocyte redox status and apoptosis induced by oxidative stress in men. Eur J Appl Physiol 95: 290-297, 2005.
42. Westerlind KC. Physical activity and cancer prevention-mechanisms. Med Sci Sports Exerc 35: 1834-1840, 2003.
43. Wu CY, Hsieh HL, Jou MJ, Yang CM. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem 90: 1477-1488, 2004.